Clinical Trial Update: Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated the safety and potential efficacy of oral green tea extract in patients with stage 0 to II chronic lymphocytic leukemia; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Green Tea Extract (Camellia sinensis extract)

Snippet

Sponsor: Mayo Clinic | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-03-13